Samsung Biologics Co.,Ltd. Financials

Market Capitalization ₩72.242 Trillion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	90.20
Forward PE	58.83
Price to Sales TTM	₩17.15
Price to Book MRQ	₩
Enterprise to Revenue	15.81
Enterprise to EBITDA	35.12

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	24.42%
Operating Margin	37.56%
Return on Assets TTM	5.17%
Return on Equity TTM	10.47%

Income Statement

Revenue TTM	₩4,211,289,620,480
Revenue per Share TTM	₩59168.93
Quarterly Revenue Growth	33.60%
Gross Profit TTM	₩2,101,942,157,312
EBITDA	₩2,081,316,835,930
Net Income to Common TTM	₩1,028,404,150,272
Diluted EPS TTM	₩12051.00
Quarterly Earnings Growth YoY	72.00%

Balance Sheet

Total Cash MRQ	₩1,568,573,489,152
Total Cash per Share MRQ	₩22038.57
Total Debt MRQ	₩
Total Debt to Equity MRQ	16.28
Current Ratio MRQ	1.35
Book Value per Share MRQ	₩

Cash Flow

Operating Cash Flow TTM	₩1,653,573,156,864
Levered Free Cash Flow TTM	₩525,972,439,040

207940 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	71,174,000
Float Shares	18,067,520
Avg 10 Volume	77,150
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	74.56%
% Held by Institutions	14.87%

Stock Price Summary

Beta	0.32
Fifty Two Week Low	₩721000.00
Fifty Two Week High	₩1113000.00
Fifty Two Week Change	26.40%
Day 50 MA	₩967980.00
Day 200 MA	₩898530.00

Dividends and Splits

Forward Annual Dividend Rate	₩
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	₩
Trailing Annual Dividend Yield	%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date